In a regulatory filing, Telomir Pharmaceuticals (TELO) reported new preclinical results evaluating the effects of its lead candidate, Telomir-1, ...

MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for ...

The psychedelic psilocybin, found in magic mushrooms, slows certain hallmarks of aging in human cells and older mice, a lab ...

Psilocybin, the psychoactive compound found in 'magic' mushrooms, may help delay aging by increasing the cellular lifespan of ...

Researchers speculating that exposure to paraben in early childhood is associated with changes in satiety hormones performed ...

In order to produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic ...

A new report from the VITAL study—a large, long-term randomized clinical trial—has found that taking vitamin D supplements ...

MAIA Biotechnology enrolls first patient in expansion of phase 2 clinical trial for ateganosine in advanced non-small cell lung cancer: Chicago Friday, July 11, 2025, 12:00 Hrs [I ...

Today, genomics is saving countless lives and even entire species, thanks in large part to a commitment to collaborative and ...

An international research team has uncovered a surprising way compartments within cells work together to defend themselves ...

The drug, which Repare recently sidelined, has shown promising activity in a patient with ALT-positive melanoma that researchers want to study in others.

Could psychedelics be the next frontier in longevity research? Early data show psilocybin delays aging in lab tests.